Get a glimpse into our company and investor data—powered by the PitchBook Platform
DebtLATEST DEAL TYPE
$250KLATEST DEAL AMOUNT
Developer of technology for early detection of cancer. The company develops technology in metabolomics, genetics and bioinformatics based on spectral analysis of metabolites to detect cancer in stage I.